Search results
Results from the WOW.Com Content Network
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
Last week, 23andMe agreed to pay $30 million in cash to settle a class-action lawsuit accusing the company of failing to protect customers whose personal information was exposed in a 2023 data breach.
The board and the CEO had been on a collision course for months, with Wojcicki pushing for a plan she had hatched to buy the company and take it private as the company’s valuation dropped from a ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
23andMe's board resigned over a "distracting difference of view" with cofounder Anne Wojcicki. The board rejected an earlier proposal by Wojcicki to take the company private.
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one sitting ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
(Reuters) - The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO ...